The Future Direction of Cardiac Pacing? by Rinaldi, Christopher Aldo
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
King’s Research Portal 
 
DOI:
10.1016/j.tcm.2016.03.003
Document Version
Peer reviewed version
Link to publication record in King's Research Portal
Citation for published version (APA):
Rinaldi, C. A. (2016). The Future Direction of Cardiac Pacing?. TRENDS IN CARDIOVASCULAR MEDICINE.
10.1016/j.tcm.2016.03.003
Citing this paper
Please note that where the full-text provided on King's Research Portal is the Author Accepted Manuscript or Post-Print version this may
differ from the final Published version. If citing, it is advised that you check and use the publisher's definitive version for pagination,
volume/issue, and date of publication details. And where the final published version is provided on the Research Portal, if citing you are
again advised to check the publisher's website for any subsequent corrections.
General rights
Copyright and moral rights for the publications made accessible in the Research Portal are retained by the authors and/or other copyright
owners and it is a condition of accessing publications that users recognize and abide by the legal requirements associated with these rights.
•Users may download and print one copy of any publication from the Research Portal for the purpose of private study or research.
•You may not further distribute the material or use it for any profit-making activity or commercial gain
•You may freely distribute the URL identifying the publication in the Research Portal
Take down policy
If you believe that this document breaches copyright please contact librarypure@kcl.ac.uk providing details, and we will remove access to
the work immediately and investigate your claim.
Download date: 01. May. 2017
Author's Accepted Manuscript
The Future Direction of Cardiac Pacing?
Christopher Aldo Rinaldi
PII: S1050-1738(16)00069-4
DOI: http://dx.doi.org/10.1016/j.tcm.2016.03.003
Reference: TCM6257
To appear in: trends in cardiovascular medicine
Cite this article as: Christopher Aldo Rinaldi, The Future Direction of
Cardiac Pacing?, trends in cardiovascular medicine, http://dx.doi.org/10.1016/j.
tcm.2016.03.003
This is a PDF file of an unedited manuscript that has been accepted for
publication. As a service to our customers we are providing this early
version of the manuscript. The manuscript will undergo copyediting,
typesetting, and review of the resulting galley proof before it is published in
its final citable form. Please note that during the production process errors
may be discovered which could affect the content, and all legal disclaimers
that apply to the journal pertain.
www.elsevier.com/locate/tcm
The future direction of cardiac pacing? 
 
Professor Christopher Aldo Rinaldi 
 
 
Address 
Guy’s and St Thomas’ Hospitals London and King’s College London 
St Thomas’ Hospital, Westminster Bridge Rd 
London UK SE1 7EH 
Tel 00442071887188 
E mail: c.rinaldi@virgin.net 
 
Disclosures 
Professor Rinaldi receives research funding and honoraria from St Jude Medical, Medtronic, 
Boston Scientific, Spectranetics and Livanova. 
 
Keywords: pacemaker, cardiac resynchronization 
 
The field of cardiac pacemakers and defibrillators has evolved exponentially in the last half 
century since the initial pacemaker implant was performed in 1958 at the Karolinska 
Institute in Sweden. The patient receiving the first implantable pacemaker, Arne Larson, 
went on to have 26 further pacemaker implants during his lifetime and when he died at the 
age of 86 he had outlived the implanter of the first device. The technology of cardiac 
implantable devices has changed dramatically and now we are currently entering a brave 
new world of pacemaker technology with a paradigm shift away from lead based 
pacemakers with their inherent drawbacks to the so called ‘leadless pacemaker’ which is 
now a reality. The current review by Austin and Kusumoto in the current edition of this 
journal is therefore timely and presents us with a comprehensive update of the current 
state of the art of cardiac pacing and also future directions for cardiac implantable device 
technology. (1) 
 
The review covers changes in pacemaker design including the rationale and use of the 
leadless pacemaker and multisite pacing for cardiac resynchronization. The Achilles heel of 
cardiac devices has long been the leads which may be prone to failure and that pose a risk if 
lead extraction is required. The ability to perform cardiac stimulation with leadless pacing is 
clearly very attractive. Several recently published studies have shown the feasibility of such 
leadless pacing technologies. (2,3) There are, however, issues relating to the to safety of 
implantation. The major limitation of the current generation of leadless pacemakers which 
is pointed out by the authors is that current devices can only deliver single chamber RV 
pacing. This therefore makes them unsuitable for patients requiring AV synchronous pacing 
and also cardiac resynchronization therapy. Similarly, defibrillation cannot be delivered via a 
leadless device. Rather than seeing this as a major limitation making them suitable only for a 
relatively small number of patients requiring pacing, we should view this as the first step in 
the development of this technology. What will be required in the next years will be the 
development of devices that can sense and pace the atrium, possibly with the delivery of 
multiple devices, to allow AV sequential pacing. The ability to deliver CRT from these devices 
by placement within the left rather than the right ventricle may also be feasible in the 
future. The review covers the use of left ventricular endocardial pacing by leadless systems 
and there is a device now available that can deliver LV endocardial pacing although it does 
require the presence of an existing trans-venous device to allow delivery of this form of 
resynchronization. (4) This area of leadless CRT will be of major interest in the coming years 
although there will be several hurdles that will have to be overcome. Firstly, demonstration 
of safety in the long and short term including implantation and also the risk of embolic 
events when these devices are used in the systemic circulation. It is likely that guidance to 
the optimal site will also be required to achieve the optimal effect as the optimal site of LV 
endocardial pacing varies between individual patients. Finally, the issue of extraction of 
these devices when they have been implanted chronically may represent a major issue. 
 
The use of multisite pacing delivered either through multiple leads or multipolar leads is 
covered. The hypothesis that multisite pacing with the ability to depolarize a larger bulk of 
myocardium more rapidly and improve CRT response is an attractive one. Several small 
predominantly single center studies have shown a benefit on acute and short term 
measures of CRT response with multisite pacing. (5) We should, however, be guarded as 
these results need to be validated with hard clinical endpoint in a multi-center randomized 
trials. The currently recruiting MORE CRT MPP study may afford us some answers to the use 
of multisite pacing and will study approximately 1800 patients looking at the effect of 
multisite pacing in non responders to standard CRT. (6) Importantly, there are potential 
pitfalls to the use of multisite pacing with the issue of potentially complicated programming 
options, potential risk of arrhythmia and, perhaps most importantly, the potential for 
reduced battery longevity. In view of these factors, it may be that multisite pacing may not 
be a panacea for all CRT patients but should be used in specific patient populations where 
response is reduced such as ischemic patients with lesser degrees of QRS prolongation 
where the benefits are not outweighed by the detrimental effects.  
 
The authors also cover the area of device based diagnosis and treatment of atrial 
arrhythmias. This is clearly an important topic and the identification of AF at an early stage 
may also impact treatments such as anticoagulation, which may reduce stroke risk. They 
also touch on the area of biological pacing with the use of cellular and gene therapies. As 
the authors rightly point out, this is still in an embryonic stage but remains an exciting area 
for future study. 
 
As the current review points out, there are many areas of innovation in the field of cardiac 
pacing that offer great promise for the future. Some of these are further advanced than 
others. It is clearly a very exciting time in this field and one which is changing rapidly. 
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